September 01, 2021
COVID-19’s lingering impact brings new considerations for treatment regimens for pediatric patients with psoriasis.
July 30, 2021
As COVID-19 eases, the FDA is breaking through its backlog and clinical trials are moving forward, opening the way for a new wave of treatments.
June 22, 2021
The pro-inflammatory transcription factor is critical for the expression of IL-23, which is known to play a role in psoriasis.
June 18, 2021
Experts present detailed guidelines on how to diagnose and treat common skin diseases and conditions in the Asian American population.
May 26, 2021
Experts evaluate efficacy and safety of regenerative skin care products.
May 03, 2021
Study findings show calcipotriene-betamethasone foam to be safe and moderately effective in skin of color patients with psoriasis but failed to meet several secondary endpoints and to demonstrate statistically significant changes.
March 16, 2021
The decision between surgical and nonsurgical options for chin augmentation continues to be a debate, but according to Michael Somenek, MD, this can be easily settled with personalized patient consultation.
March 09, 2021
Recently approved treatments for acne are focused on decreasing activity within the sebaceous gland.
March 02, 2021
The investigational neuromodulator, evaluated in clinical trials as a treatment for glabellar lines and as a combined therapy for glabellar, dynamic forehead, and lateral canthal lines, is quickly nearing an approval by the FDA.
February 25, 2021
Cancer staging systems for squamous cell carcinoma have helped improve dermatologists’ ability to accurately stage the cancer, according to one expert.
